Review Volume 13, Issue 11 pp 15659—15673

Exploring stroke risk and prevention in China: insights from an outlier

Age-standardized 5-year survival increases of cancers in different countries, 2000-2014. ALL: acute lymphoblastic leukemia; LPM: lymphoidmalignancies; MLM: myeloidmalignancies; (C): children; (A): adult. The percentage of survival increases are classified as: 1 score: no increase; 2 score: 0-5%; 3 score: 5-10%; 4 score: 10-20%; 5 score: >20%. Data are extracted from the third cycle of the CONCORD programme (CONCORD-3) that established global surveillance of trends in cancer survival 2000-2014 [88].

Figure 3. Age-standardized 5-year survival increases of cancers in different countries, 2000-2014. ALL: acute lymphoblastic leukemia; LPM: lymphoidmalignancies; MLM: myeloidmalignancies; (C): children; (A): adult. The percentage of survival increases are classified as: 1 score: no increase; 2 score: 0-5%; 3 score: 5-10%; 4 score: 10-20%; 5 score: >20%. Data are extracted from the third cycle of the CONCORD programme (CONCORD-3) that established global surveillance of trends in cancer survival 2000-2014 [88].